News - Xarelto, Pfizer

Filter

Current filters:

XareltoPfizer

Popular Filters

Bayer/Janssen's Xarelto poised to lead sales in VTE market: report

30-08-2013

German drug major Bayer (BAYN: DE) and Johnson & Johnson (NYSE: JNJ) subsidiary Janssen's Xarelto (rivaroxaban)…

BayerBristol-Myers SquibbCardio-vascularEliquisGlobalJanssenJohnson & JohnsonMarkets & MarketingPfizerPharmaceuticalXarelto

Xarelto and Eliquis set to displace current therapies in DVT/PE

28-03-2013

Clinical data and the opinions of interviewed thought leaders indicate that there is little to distinguish…

BayerBristol-Myers SquibbCardio-vascularEliquisEuropeJohnson & JohnsonMarkets & MarketingNorth AmericaPfizerPharmaceuticalXarelto

Outlook for VTE treatment and prophylaxis market

14-12-2011

Driven primarily by the launches and strong uptake of oral anticoagulants, the combined markets for drugs…

BayerBristol-Myers SquibbCardio-vascularEliquisJohnson & JohnsonMarkets & MarketingPfizerPharmaceuticalXarelto

Back to top